Methylprednisolone Addition in IVF Treatment of Infertile Couples
Launched by UNIVERSITAIR ZIEKENHUIS BRUSSEL · Oct 13, 2010
Trial Information
Current as of June 28, 2025
Unknown status
Keywords
ClinConnect Summary
The aim is to investigate any potential advantages of adding cortisone supplementation from the follicular phase onwards with regard to premature luteinization, oocyte quality, embryo quality and pregnancy outcome.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • less than 36, more than 10 antral follicles, FSH\<12
- Exclusion Criteria:
- • endometriosis stage III\&IV,
About Universitair Ziekenhuis Brussel
Universitair Ziekenhuis Brussel (UZ Brussel) is a leading academic medical center in Belgium, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent institution affiliated with the Vrije Universiteit Brussel, UZ Brussel integrates cutting-edge medical research with high-quality patient care. The hospital's multidisciplinary teams are dedicated to exploring novel therapeutic approaches and contributing to the development of evidence-based treatments, ensuring the highest standards of safety and efficacy in clinical research. With a strong focus on collaboration and knowledge dissemination, UZ Brussel plays a pivotal role in shaping the future of medicine and improving patient outcomes.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Thessaloniki, Pylaia, Greece
Patients applied
Trial Officials
Basil Tarlatzis, Professor
Study Chair
BioGenesis
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials